LianBio - LIANY

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2023 · Q3 2023
Value (USD)
Total reported value ($000)
$275.7M
QoQ value delta ($000)
+$181.3M (+192.15%)
Implied price effect (QoQ)
+199.99%
Shares
Total shares
61,679,895
QoQ shares delta
-1,654,457 (-2.61%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (LIANY)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2023)

Top 25 only Full list
Early Q3 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
PERCEPTIVE ADVISORS LLC 257,256 57,558,451 5.74%
VIKING GLOBAL INVESTORS LP 15,931 3,564,173 0.06%
RENAISSANCE TECHNOLOGIES LLC 1,547 346,000 0.0%
MILLENNIUM MANAGEMENT LLC 188 42,074 0.0%
Invesco Ltd. 170 38,039 0.0%
AXXCESS WEALTH MANAGEMENT, LLC 121 27,126 0.0%
GEODE CAPITAL MANAGEMENT, LLC 111 25,027 0.0%
STIFEL FINANCIAL CORP 82 18,500 0.0%
OSAIC HOLDINGS, INC. 78 17,555 0.0%
BANK OF AMERICA CORP /DE/ 60 13,424 0.0%
TWO SIGMA INVESTMENTS, LP 59 13,291 0.0%
COMMONWEALTH EQUITY SERVICES, LLC 48 10,830 0.0%
UBS Group AG 19 4,399 0.0%
MORGAN STANLEY 4 1,006 0.0%